FMR LLC 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 10:40 am Sale | 2024-11-08 | 13G | Xilio Therapeutics, Inc. XLO | FMR LLC | 1,395,853 3.175% | -511,818 (-26.83%) | Filing |
| 2023-02-09 08:14 am Sale | 2023-02-09 | 13G | Xilio Therapeutics, Inc. XLO | FMR LLC | 1,907,671 6.944% | -662,599 (-25.78%) | Filing |
| 2022-02-09 10:04 am Sale | 2022-02-08 | 13G | Xilio Therapeutics, Inc. XLO | FMR LLC | 2,570,270 9.357% | -87,400 (-3.29%) | Filing |
| 2021-11-04 09:15 am Purchase | 2021-11-04 | 13G | Xilio Therapeutics, Inc. XLO | FMR LLC | 2,657,670 9.966% | 2,657,670 (New Position) | Filing |